A 4-week, randomized, double-blind, placebo-controlled trial showed a significantly improved 24-h blood glucose control [126], and a subsequent pooled post hoc analysis including more than 700 patients provides evidence of the safety and efficacy of a 52 weeks mean follow-up of use of teneligliptin 20 mg daily as monotherapy or in combination with sulfonylurea, glinide, biguanide or -glucosidase inhibitor in Japanese patients with T2DM [127]
Researchers studying the retatrutide for research compound can consult several credible scientific sources for additional information: Coskun T, Urva S, Roell WC, et al
On average, GLP-1 medications can lead to a weight loss of around 2-4 kilograms, or about 4.4-8.8 pounds, over 6 months to a year
as GLP-1 medications stabilize blood glucose levels and reduce glycemic variability, patients frequently experience resolution of these symptoms and perceive increased vitality
Extended-duration safety data will only be available after full clinical trials and regulatory review
Clean the Vial Tops Wipe the rubber stopper of both the retatrutide vial and BAC water vial with an alcohol swab
